We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DNP:GPWDino Polska SA Analysis

Data as of 2026-03-11 - not real-time

$10.21

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at $10.21, comfortably above the 20‑day SMA of 10.43 and the 50‑day SMA of 10.20, signalling a bullish price trend, while the 200‑day SMA sits at 9.99, reinforcing the long‑term up‑trend. Technicals show a neutral RSI of 42 and a bearish MACD histogram, indicating short‑term momentum weakness, but the price remains supported at $10.05 with resistance near $10.65. Valuation metrics are compelling: a trailing P/E of 8.8 is well below the industry average of 16.6 and the P/B of 1.10 sits just above book value, suggesting the market may be undervaluing the fund.
Dividend attractiveness is a key driver, with a 7.57% yield and a payout ratio of 67%, backed by solid operating cash flow of $235.9 M and free cash flow of $64.1 M, indicating sustainability. The fund’s beta of 0.42 and 30‑day volatility of 11.8% point to low market‑risk exposure, though a high debt‑to‑equity of 31.6% warrants caution. Overall, the combination of low multiples, strong cash generation, and high yield positions DNP as a value‑oriented, income‑focused investment with moderate risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price is near technical support at $10.05
  • High dividend yield provides downside cushion
  • Bearish MACD suggests limited upside in the near term

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued P/E relative to industry peers
  • Sustainable dividend backed by strong cash flow
  • Bullish SMA alignment indicating a continuing uptrend

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Stable utility exposure offers defensive characteristics
  • Elevated debt‑to‑equity may limit future flexibility
  • Consistent income generation supports long‑term holding

Key Metrics & Analysis

Financial Health

Revenue Growth8.90%
Profit Margin266.32%
P/E Ratio8.8
ROE12.67%
ROA1.78%
Debt/Equity31.58
P/B Ratio1.1
Op. Cash Flow$235.9M
Free Cash Flow$64.1M
Industry P/E16.6

Technical Analysis

TrendBullish
RSI42.2
Support$10.05
Resistance$10.65
MA 20$10.43
MA 50$10.20
MA 200$9.99
MACDBearish
VolumeStable
Fear & Greed Index78.16

Valuation

Fair Value$0.58
GradeUndervalued
TypeValue
Dividend Yield7.57%

Risk Assessment

Beta0.42
Volatility11.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.